newsfilter
← Latest News
GlobeNewswire·

U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus

Mechelen, Belgium; 24 August 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug